None listed
Conditions
Interventions
Drug : 1. Drug for study
Nutritional supplements: Yungjin Pharm ‘Harmonilan Solution’
2. Drug dose, frequency, duration, and route of intake
Investigators record the quantity of provided drug.
3.
Sponsors
Soon Chun Hyang University Hospital Bucheon
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - The age of over 19 and under 80 years old - ECOG ((Eastern Cooperative Oncology Group) : 0-1 - The subject undergo radical gastrectomy for gastric cancer - Without onstructive symptoms before surgery - Agreed informed consent
Exclusion criteria
Exclusion criteria: - Out of inclusion criteria - The subject who intake nutritional supplement over 1 month before surgery - Presence of postoperative complication more than grade 3 in Clavien-Dindo classification before discharge - Vulnerable subject (Lack of ability, pregnancy) - Those who are judged to be inappropriate to participate in this clinical trial based on the investigator's medical opinion - Subjects who are sensitive to milk or have a history of allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rates of body weight (%) | — |
Secondary
| Measure | Time frame |
|---|---|
| The rates of body weight (%);Nutritional status through the PNI (prognostic nutritional index) score;Nutritional status through the ICD-9;The amount of nutritional intake;Nutrient density;Nutrient Adequacy Ratio;Index of Nutritional Quality;Quality of life through the QLQ-C30;Quality of life through the QLQ-STO22;Adverse event and complication;Vital sign;Results of laboratory value | — |
Countries
Korea, Republic of
Contacts
Public ContactIn Cho
Soon Chun Hyang University Hospital Bucheon
Outcome results
None listed